Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
381
2011. Vol. 183, N. 12. P. 1359-1366.
Singh S., Singh P.P., Singh A.G. et al. Statins are associated with a reduced risk of hepatocellular cancer:
asystematic review and meta-analysis // Gastroenterology. 2013.
Vol. 144, N. 2. P. 323-332.
Singh V., Patel N.J., Rodriguez A.P. et al. Percutaneous coronary intervention in patients with end-stage
liver disease // Am. J. Cardiol. 2016. Vol. 117, N. 11. P. 1729-
1734.
Sircar D., Chatterjee S., Waikhom R. et al. Efficacy of febuxostat for slowing the GFR decline in patients
with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled
trial // Am. J. Kidney Dis. 2015.
Vol. 66, N. 6. P. 945-950.
Slatore C.G., Bryson C.L., Au D.H. The association of inhaled corticosteroid use with serum glucose
concentration in a large cohort // Am. J. Med. 2009. Vol. 122.
P. 472-478.
Slavich M., Maranta F., Fumero A. et al. Long-term preservation of left ventricular systolic function in
patients with refractory angina pectoris and inducible myocardial ischemia on optimal medical therapy
// Am. J. Cardiol. 2016. Vol. 117, N. 10. P. 1558-1561.
Smit M., Dolman K.M., Honig A. et al. Mirtazapine in pregnancy and lactation - A systematic review //
Eur. Neuropsychopharmacol. 2016. Vol. 26, N. 1. P. 126-135. Smith B.M., Prince M.R., Hoffman E.A. et al.
Impaired left ventricular filling in
COPD and emphysema: is it the heart or the lungs? // Chest. 2013. Vol. 144, N. 4. P. 1143-1151.
Sode B.F., Dahl M., Nordestgaard B.G. Myocardial infarction and other co-morbidities in patients with
chronic obstructive pulmonary disease: a Danish Nationwide Study of 7.4 million individuals // Eur.
Heart J. 2011. Vol. 32, N. 19. P. 2365-2375.
Solomon D.H., Massarotti E., Garg R. et al. Association between disease-modifying antirheumatic drugs
and diabetes risk in patients with rheumatoid arthritis and
psoriasis // JAMA. 2011. Vol. 305, N. 24. P. 2525-2531.
Song H.J., Lee J., Kim Y.J. et al. β1 selectivity of β-blockers and reduced risk of fractures in elderly
hypertension patients // Bone. 2012. Vol. 51, N. 6. P. 1008-1015.
Song P.S., Kim D.-K., Seo G.-W. et al. Spironolactone lowers the rate of repeat revascularization in acute
myocardial infarction patients treated with percutaneous coronary intervention // Am. Heart J. 2014.
Vol. 168. P. 346-353.e3.
Song R., Chen L., Chen Y. et al. Comparison of glyburide and insulin in the management of gestational
diabetes: a meta-analysis // PLoS One. 2017. Vol. 12, N. 8. Article
ID e0182488.
Soo C.G., Torre P.K., Yolland T.J., Shatwell M.A. Clopidogrel and hip fractures, is
it safe? // BMC Musculoskelet. Disord. 2016. Vol. 17. P. 136.
Источник KingMed.info
382
Sorensen R., Hansen M.L., Abildstrom S.Z. et al. Risk of bleeding in patients with acute myocardial
infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in
Denmark // Lancet. 2009. Vol. 374. P. 1967-1974.
Soriano J.B., Rigo F., Guerrero D. et al. High prevalence of undiagnosed airflow limitation in patients
with cardiovascular disease // Chest. 2010. Vol. 137, N. 2.
P. 333-340.
Soto-Campos J.G., Plaza V., Soriano J.B. et al. Causes of death in asthma, COPD and non-respiratory
hospitalized patients // BMC Pulm. Med. 2013. Vol. 13, N. 7.
Sousa P.A., Providência R., Albenque J.-P. et al. Impact of free thyroxine on the outcomes of left atrial
ablation procedures // Am. J. Cardiol. 2015. Vol. 116, N. 12.
P. 1863-1868.
Souverein P.C., Berard A., Van Staa T.P. et al. Use of oral glucocorticoids and risk of cardiovascular and
cerebrovascular disease in a population based case-control
study // Heart. 2004. Vol. 90, N. 8. P. 859-865.
Soyseth V., Brekke P.H., Smith P. et al. Statin use is associated with reduced mortality in COPD // Eur.
Respir. J. 2007. Vol. 29. P. 279-283.
Spahr L., Coeytaux A., Giostra E. et al. Histamine H1 blocker hydroxyzine improves sleep in patients with
cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial // Am. J.
Gastroenterol. 2007. Vol. 102, N. 4. P. 744-753.
Spence J., Viscoli C., Inzucchi S. et al. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A
Post Hoc Analysis of the IRIS Randomized Clinical Trial // JAMA Neurol. 2019.
Squizzato A., Galli M., Romualdi E. et al. Statins, fibrates, and venous thromboem-
bolism: a meta-analysis // Eur. Heart J. 2010. Vol. 31, N. 10. P. 1248-1256.
Sriuttha P., Sirichanchuen B., Permsuwan U. et al. Hepatotoxicity of Nonsteroidal Anti-Inflammatory
Drugs: A Systematic Review of Randomized Controlled Trials //
Int. J. Hepatol. 2018. 5253623.
Stacy S.R., Suarez-Cuervo C., Berger Z. et al. Role of troponin in patients with chronic kidney disease
and suspected acute coronary syndrome: asystematic review // Ann. Intern. Med. 2014. Vol. 161. P.
502-512.
Stamboul K., Zeller M., Fauchier L. et al. Incidence and prognostic significance of silent atrial fibrillation
in acute myocardial infarction // Int. J. Cardiol. 2014. Vol. 174,
N. 3. P. 611-617.
Stamp L.K., Chapman P.T., Barclay M.L. et al. How much allopurinol does it take to get to target urate?
Comparison of actual dose with creatinine clearance-based
dose // Arthritis Res. Ther. 2018. Vol. 20, N. 1. P. 255.
Starr J.B., Tirschwell D.L., Becker K.J. et al. Labetalol use is associated with increased in-hospital infection
compared with nicardipine use in intracerebral hemorrhage // Stroke. 2017. Vol. 10. P. 2693-2698.
Источник KingMed.info
383
Stefan M.S., Rothberg M.B., Priya A. et al. Association between beta-blocker therapy and outcomes in
patients hospitalised with acute exacerbations of COPD with underlying ischaemic heart disease, heart
failure or hypertension // Thorax. 2012.
Vol. 67, N. 11. P. 977-984.
Stefan M.S., Shieh M., Spitzer K.A. et al. Association of antibiotic treatment with outcomes in patients
hospitalized for an asthma exacerbation treated with systemic corticosteroids // JAMA Intern. Med.
2019.
Stein J. Minimize weight gain to maximize smoking-cessation benefit // American College of
Cardiology 2013 Scientific Sessions. San Francisco, 2013.
URL: http://www. theheart.org/article/1517161.do.
Steinberg Z.L., Dominguez-Islas C.P., Otto C.M. et al. Maternal and fetal outcomes of anticoagulation in
pregnant women with mechanical heart valves // J. Am.
Coll. Cardiol. 2017. Vol. 69, N. 22. P. 2681-2691.
Steineck I., Cederholm J., Eliasson B. et al. Insulin pump therapy, multiple daily injections, and
cardiovascular mortality in 18 168 people with type 1 diabetes: observational study // BMJ. 2015. Vol.
350. Article ID h3234.
Stergiou G.S., Kollias A., Destounis A., Tzamouranis D. Automated blood pressure measurement in atrial
fibrillation: a systematic review and meta-analysis //
J. Hypertens. 2012. Vol. 30, N. 11. P. 2074-2082.
Stolk L.M., de Vries F., Ebbelaar C. et al. Risk of myocardial infarction in patients with atrial fibrillation
using vitamin K antagonists, aspirin or direct acting oral anticoagulants // Br. J. Clin. Pharmacol. 2017.
Vol. 83, N. 8. P. 1835-1843.
Stoschitzky K., Stoschitzky G., Lercher P., Brussee H. et al. Propafenone shows class Ic and class II
antiarrhythmic effects // Europace. 2016. Vol. 18, N. 4. P. 568-571.
Strandberg T.E., Strandberg A.Y., Salomaa V.V. et al. Explaining the obesity paradox: cardiovascular risk,
weight change, and mortality during long-term follow-up in men // Eur. Heart J. 2009. Vol. 30, N. 14. P.
1720-1727.
Struijs J.N., Baan C.A., Schellevis F.G. etal. Comorbidity in patients with diabetes mellitus: impact on
medical health care utilization // BMC Health Serv. Res. 2006.
Vol. 6. P. 84.
Stuijver D.F., Majoor C.J., van Zaane B. et al. Use of oral glucocorticoids and the risk of pulmonary
embolism // Chest. 2013. Vol. 143. N. 5. P. 1337-1342.
Su N., Li Y., Xu T. et al. Exenatide in obese or overweight patients without diabetes: a systematic review
and meta-analyses of randomized controlled trials // Int. J. Cardiol.
2016. Vol. 219. P. 293-300.
Su X., Zhang L., Lv J. et al. Effect of statins on kidney disease outcomes: asystematic review and meta-
analysis // Am. J. Kidney Dis. 2016. Vol. 67, N. 6. P. 881-892.
Источник KingMed.info
384
Suhrs H., Raft K., Bové K. et al. Effect of liraglutide on body weight and microvascular function in non-
diabetic overweight women with coronary microvascular dysfunction // Intern. J. Cardiology. 2019. Vol.
283. P. 28-34.
Suissa S., Kezouh A., Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression //
Am. J. Med. 2010. Vol. 123, N. 11. P. 1001-1006.
Sujan A. et al. Associations of maternal antidepressant use during the first trimester of pregnancy with
preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity
disorder in offspring // JAMA. 2017. Vol. 317.
P. 1553-1562.
Sun S., Cui Z., Zhou M. et al. Proton pump inhibitor monotherapy and the risk of cardiovascular events
in patients with gastro-esophageal reflux disease: a metaanalysis // Neurogastroenterol. Motil. 2016.
Vol. 29, N. 2. doi: 10.1111/nmo.12926.
Sung J.J.Y., Lau J.Y.W., Ching J.Y.L. et al. Continuation of low-dose aspirin therapy in peptic ulcer
bleeding // Ann. Intern. Med. 2010. Vol. 152, N. 1. P. 1-9.
Sutton N.R., Seth M., Ruwende C., Gurm H.S. Outcomes of patients with atrial fibrillation undergoing
percutaneous coronary intervention // J. Am. Coll. Cardiol. 2016. Vol. 68, N. 9. P. 895-904.
Suzuki T., Isselbacher E.M., Nienaber C.A. et al. Type-selective benefits of medications in treatment of
acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]) // Am. J.
Cardiol. 2012. Vol. 109, N. 1. P. 122-127.
Tai V., Leung W., Grey A., Reid I.R. et al. Calcium intake and bone mineral density: systematic review and
meta-analysis // BMJ. 2015. Vol. 351. Article ID h4580.
Tajeu G.S., Booth J.N., Colantonio L.D. et al. Incident cardiovascular disease among adults with blood
pressure <140/90 mm Hg // Circulation. 2017. Vol. 136, N. 9.
P. 798-812.
Takeuchi K., Abe K., Yasujima M. et al. No adverse effect of non-steroidal antiinflammatory drugs,
sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in
elderly hypertensive patients // Tohoku J. Exp. Med. 1991. Vol. 165. P. 201-208.
Tanboga I.H., Topcu S. The risk of atrial fibrillation with ivabradine treatment: a meta-analysis with trial
sequential analysis of more than 40 000 patients //
Clin. Cardiol. 2016. Vol. 39, N. 10. P. 615-620.
Tandon P., Abraldes J.G., Berzigotti A. et al. Renin-angiotensin-aldosterone inhibitors in the reduction
of portal pressure: a systematic review and meta-analysis //
J. Hepatol. 2010. Vol. 53, N. 2. P. 273-282.
Tang H.L. et al. Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 inhibitors on
fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized
controlled trials // Diabetes Obes. Metab.
2016. Vol. 18, N. 2. P. 1199-1206.
Tang W.H.W., Wu Y., Britt E.B. et al. Detectable subclinical myocardial necrosis is associated with
cardiovascular risk in stable patients with diabetes // Diabetes Care.
Источник KingMed.info
385
2013. Vol. 36, N. 5. P. 1126-1131.
Tanner R.M., Calhoun D.A., Bell E.K. et al. Prevalence of apparent treatment-resistant hypertension
among individuals with CKD // Clin. J. Am. Soc. Nephrol. 2013.
Vol. 8, N. 9. P. 1583-1590.
Taylor G., McNeill A., Girling A. et al. Change in mental health after smoking cessation: systematic
review and meta-analysis // BMJ. 2014. Vol. 348. Article ID g1151.
Thein P.M., White K., Banker K. et al. Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the
Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery // System. Rev. Heart Lung Circ. 2018.
Vol. 27, N. 3. P. 310-321.
Tentzeris I., Rohla M., Jarai R. et al. Influence of high-dose highly efficient statins on short-term
mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary
syndromes // Am. J. Cardiol. 2014. Vol. 113, N. 7. P. 1099-1104.
Thanassoulis G., Brophy J.M., Richard H. et al. Gout, allopurinol use, and heart failure outcomes // Arch.
Intern. Med. 2010. Vol. 170, N. 15. P. 1358-1364.
Thein P.M., White K., Banker K. et al. Preoperative use of oral beta-adrenergic blocking agents and the
incidence of new-onset atrial fibrillation after cardiac surgery. A systematic review and meta-analysis //
Heart Lung Circ. 2018. Vol. 27, N. 3. P. 310-321.
Thiele M., Albillos A., Abazi R. et al. Non-selective beta-blockers may reduce risk of hepatocellular
carcinoma: a meta-analysis of randomized trials // Liver Int. 2015.
Vol. 35, N. 8. P. 2009-2016.
Thomsen R.W., Riis A., Christensen S. et al. Diabetes and 30-day mortality from peptic ulcer bleeding
and perforation: a Danish population-based cohort study //
Diabetes Care. 2006. Vol. 29. P. 805-810.
Tieu A., Velenosi T., Kucey A. et al. β-Blocker dialyzability in maintenance hemo-dialysis patients: a
randomized clinical trial // Clin. J. Am. Soc. Nephrol. 2018. Vol. 4.
P. 604-611.
Tinetti M.E., Han L., Lee D.H. et al. Antihypertensive medications and serious fall injuries in a nationally
representative sample of older adults // JAMA Intern. Med. 2014.
Vol. 174, N. 4. P. 588-595.
Tisminetzky M., Chen H.-Y., McManus D.D. et al. Trends in the magnitude of, and patient characteristics
associated with, multiple hospital readmissions after acute
myocardial infarction // Am. J. Cardiol. 2016. Vol. 118, N. 8. P. 1117-1122.
Tkáč I., Raz I. Combined analysis of three large interventional trials with gliptins indicates increased
incidence of acute pancreatitis in patients with type 2 diabetes //
Diabetes Care. 2017. Vol. 40, N. 2. P. 284-286.
Источник KingMed.info
386
Toh S., Hampp C., Reichman M.E. et al. Risk for hospitalized heart failure among new users of
saxagliptin, sitagliptin, and other antihyperglycemic drugs: aretrospective cohort study // Ann. Intern.
Med. 2016. Vol. 164. P. 705-714.
Toshiaki N., Toshiharu N., Shinji S. et al. Association of kidney function with coronary atherosclerosis
and calcification in autopsy samples from Japanese elders: the
Hisayamastudy // Am. J. Kidney Dis. 2010. Vol. 55, N. 1. P. 21-30.
Toulis K.A., Hemming K., Stergianos S. et al. β-Adrenergic receptor antagonists and fracture risk: a
meta-analysis of selectivity, gender, and site-specific effects //
Osteoporos. Int. 2014. Vol. 25, N. 1. P. 121-129.
Trelle S., Reichenbach S., Wandel S. et al. Cardiovascular safety of non-steroidal anti-inflammatory
drugs: network meta-analysis // BMJ. 2011. Vol. 342. Article ID
c7250.
Tsai W., Wu H., Peng Y. et al. Association of intensive blood pressure control and kidney disease
progression in nondiabetic patients with chronic kidney disease.
A systematic review and meta-analysis // JAMA Intern. Med. 2017. Vol. 177, N. 6. P. 792-799.
Tse S.M., Li L., Butler M.G. et al. Statin exposure is associated with decreased asthma-related emergency
department visits and oral corticosteroid use // Am. J. Respir. Crit. Care Med. 2013. Vol. 188, N. 9. P.
1076-1082.
Tsimploulis A., SheriffH.M., Lam P.H. et al. Systolic-diastolic hypertension versus isolated systolic
hypertension and incident heart failure in older adults: insights from the cardiovascular health study //
Int. J. Cardiol. 2017. Vol. 235. P. 11-16.
Tsujimoto S., Mokuda S., Matoba K. et al. The prevalence of endoscopic gastric mucosal damage in
patients with rheumatoid arthritis // PLoS One. 2018. Vol. 13, N. 7. Article ID e0200023.
Tsujimoto T., Kajio H., Shapiro M. et al. Risk of all-cause mortality in diabetic patients taking beta-
blockers // Mayo Clin. Proc. 2018. Vol. 4. P. 409-418.
Tsujimoto T., Sugiyama T., Kajio H. et al. Effects of beta-blockers on all-cause mortality in patients with
type 2 diabetes and coronary heart disease // Diabetes Obes. Metab. 2017. Vol. 19, N. 6. P. 800-808.
Tsujimoto T., Sugiyama T., Shapiro M. et al. Risk of cardiovascular events in patients with diabetes
mellitus on β-blockers // Hypertension. 2017. Vol. 1. P. 103-110.
Tsujimoto T., Yamamoto-Honda R., Kajio H. et al. Vital signs, QT prolongation, and newly diagnosed
cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients // Diabetes
Care. 2014. Vol. 37, N. 1. P. 217-225.
Tsujimoto T., Kajio H. Strategies for glycemic control in nonobese and obese type 2 diabetic patients
with coronary artery disease // Intern. J. Cardiology. 2019. Vol. 282. P. 1-6.
Tu B., Rich B., Labos C., Brophy J.M. Coronary revascularization in diabetic patients: a systematic review
and Bayesian network meta-analysis // Ann. Intern. Med. 2014. Vol. 161. P. 724-732.
Turagam M., Vuddanda V., Verberkmoes N. et al. Epicardial left atrial appendage exclusion reduces
blood pressure in patients with atrial fibrillation and hypertension // J. Am. Coll. Cardiol. 2018. Vol. 12.
P. 1346-1353.
Источник KingMed.info
387
Turak O., Canpolat U., Özcan F. et al. Usefulness of preprocedural serum uric acid level to predict
restenosis of bare metal stents // Am. J. Cardiol. 2014. Vol. 113, N. 2. P. 197-202.
Tzoulaki I. et al. Risk of cardiovascular disease and all-cause mortality among patients with type 2
diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice
research database // BMJ. 2009. Vol. 339. Article ID
b4731.
Udell J.A., Cavender M.A., Bhatt D.L. et al. Glucose-lowering drugs or strategies and cardiovascular
outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
// Lancet Diabetes Endocrinol. 2015. Vol. 3. P. 356-366.
Ueda P., Svanström H., Melbye M. et al. Sodium glucose cotransporter 2 inhibitors and risk of serious
adverse events: nationwide register based cohort study // BMJ. 2018.
Vol. 363. Article ID k4365.
Uhm J., Shim J., Wi J. et al. First-degree atrioventricular block is associated with advanced
atrioventricular block, atrial fibrillation and left ventricular dysfunction in patients with hypertension //
J. Hypertension. 2014. P. 32.
Ukaigwe A., Karmacharya P., Mahmood M. et al. Meta-analysis on efficacy of statins for prevention of
contrast-induced acute kidney injury in patients undergoing coronary angiography // Am. J. Cardiol.
2014. Vol. 114. P. 1295-1302.
Ullal A.J., Kaiser D.W., Fan J. et al. Safety and clinical outcomes of catheter ablation of atrial fibrillation in
patients with chronic kidney disease // J. Cardiovasc. Electrophysiol. 2017. Vol. 28, N. 1. P. 39-48.
Uptal D.P., Melissa A.G., Gregg C.F. et al. Associations between worsening renal function and 30-day
outcomes among Medicare beneficiaries hospitalized with heart failure // Am. Heart J. 2010. Vol. 160,
N. 1. P. 132-138.
Vamos M., Erath J.W., Hohnloser S.H. Digoxin-associated mortality: a systematic review and meta-
analysis of the literature // Eur. Heart J. 2015. Vol. 36. P. 1831-1838.
Van Dalem J., Brouwers M.C.G.J., Stehouwer C.D.A. et al. Risk of hypoglycaemia in users of
sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite
group: population based cohort study // BMJ. 2016. Vol. 354. Article ID i3625.
Van den Akker M., Buntinx F., Metsemakers J.F. et al. Multimorbidity in general practice: prevalence,
incidence, and determinants of co-occurring chronic and recurrent diseases // J. Clin. Epidemiol. 1998.
Vol. 51, N. 5. P. 367-375.
Van den Borst B., Gosker H.R., Zeegers M.P. et al. Pulmonary function in diabetes // Chest. 2010. Vol.
138, N. 2. P. 393-406.
Van der Hooft C.S.,Heeringa J.,Brusselle G.G. et al. Corticosteroids and the risk of atrial fibrillation //
Arch. Intern. Med. 2006. Vol. 166. P. 1016-1020.
Van Der Meersch H., De Bacquer D., De Vriese A.S. Vitamin K antagonists for stroke prevention in
hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis // Am. Heart J. 2017.
Vol. 184. P. 37-46.
Vardeny O., Claggett B., Udell J.A. et al. Influenza vaccination in patients with chronic heart failure: the
PARADIGM-HF trial // JACC Heart Fail. 2016. Vol. 4, N. 2.
Источник KingMed.info
388
P. 152-158.
Vardeny O., Wu D., Desai A. et al. Influence of baseline and worsening renal function on efficacy of
spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone
Evaluation Study) // J. Am. Coll. Cardiol. 2012.
Vol. 60, N. 20. P. 2082-2089.
Vargas-Santos A.B., Peloquin C.E., Zhang Y., Neogi T. Association of chronic kidney disease with
allopurinol use in gout treatment // JAMA Intern. Med. 2018. Vol. 178,
N. 11. P. 1526-1533.
Varmdal T., Janszky I., Bakken I.J. et al. Percutaneous coronary intervention as a
trigger for stroke // Am. J. Cardiol. 2016. Vol. 119, N. 1. P. 35-39.
Vazquez E., Sanchez-Perales C., Garcia-Garcia F. et al. Atrial fibrillation in incident dialysis patients //
Kidney Int. 2009. Vol. 76, N. 3. P. 324-330.
Venkatesh P.G., Njei B., Sanaka M.R., Navaneethan U. Risk of comorbidities and outcomes in patients
with lower gastrointestinal bleeding - a nationwide study // Int.
J. Colorectal. Dis. 2014. Vol. 29, N. 8. P. 953-960.
Verma S., Farkouh M.E., Yanagawa B. et al. Comparison of coronary artery bypass surgery and
percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised
controlled trials // Lancet Diabetes Endocrinol. 2013. Vol. 1, N. 4. P. 317-328.
Verhamme K., Mosis G., Dieleman J. et al. Spironolactone and risk of upper gastrointestinal events:
population based case-control study // BMJ. 2006. Vol. 333. P. 330.
Viazis N., Keyoglou A., Kanellopoulos A.K. et al. Selective serotonin reuptake inhibitors for the
treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study // Am. J.
Gastroenterol. 2012. Vol. 107, N. 11. P. 1662-1667.
Vinogradova Y., Coupland C., Hippisley-Cox J. et al. Use of hormone replacement therapy and risk of
venous thromboembolism: nested case-control studies using the QResearch and CPRD databases //
BMJ. 2019. Vol. 364. Article ID k4810.
Viswanathan A., Rakich S.M., Engel C. et al. Antiplatelet use after intracerebral
hemorrhage // Neurology. 2006. Vol. 66, N. 2. P. 206-209.
Vlachopoulos C.V., Printzios-Terentes D.G., Ioakeimidis N.K. et al. Prediction of cardiovascular events
and all-cause mortality with erectile dysfunction // Circ.
Cardiovasc. Qual. Outcomes. 2013. Vol. 6, N. 1. P. 99-109.
Voican C.S., Corruble E., Naveau S., Perlemuter G. Antidepressant-induced liver injury: a review for
clinicians // Am. J. Psychiatry. 2014. Vol. 171. P. 404-415.
Voskoboinik A., Moskovitch J., Plunkett G. et al. Cardioversion of atrial fibrillation in obese patients:
Results from the Cardioversion-BMI randomized controlled trial //
J. Cardiovasc. Electrophysiol. 2019. Vol. 30, N. 2. P. 155-161.
Источник KingMed.info
389
Vozoris N.T., Wang X., Fischer H.D. et al. Incident opioid drug use and adverse respiratory outcomes
among older adults with COPD // Eur. Respir. J. 2016. Vol. 48,
N. 3. P. 683-693.
Wacker J.R., Wagner B.K., Briese V. et al. Antihypertensive therapy in patients with pre-eclampsia: a
prospective randomisedmulticentre study comparing dihydralazine with urapidil // Eur. J. Obstet.
Gynecol. Reprod. Biol. 2006. Vol. 127, N. 2. P. 160-165.
Walsh C.R., Lloyd-Jones D.M., Camargo C.A. et al. Clinical trials of unfractiona-ted heparin and low-
molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the
results apply to all patients? // Am. J. Cardiol. 2000.
Vol. 806. P. 908-912.
Wang B., Liu S., Li L. et al. Non-thyroidal illness syndrome in patients with cardiovascular diseases: a
systematic review and meta-analysis // Int. J. Cardiol. 2017.
Vol. 226. P. 1-10.
Wang C.S., Wang S.T., Yao W.J. et al. Hepatitis C virus infection and the development of type 2 diabetes
in a community-based longitudinal study // Am. J. Epidemiol.
2007. Vol. 166, N. 2. P. 196-203.
Wang H.S., Wang Z.W., Yin Z.T. et al. Carvedilol for prevention of atrial fibrillation after cardiac surgery:
a meta-analysis // PLoS One. 2014. Vol. 9, N. 4. Article ID
e94005.
Wang I.K., Tsai I.J., Chen P.C. et al. Hypertensive disorders in pregnancy and subsequent diabetes
mellitus: a retrospective cohort study // Am. J. Med. 2012. Vol. 125,
N. 3. P. 251-257.
Wang M., Cai S., Sun L. et al. Safety and efficacy of early radiofrequency catheter ablation in patients
with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis // Cardiol. J.
2016. Vol. 23, N. 4. P. 416-421.
Wang M., Liou J., Lin C. et al. Association of cardiovascular risk with inhaled long-acting
bronchodilators in patients with chronic obstructive pulmonary disease: a nested case-control study //
JAMA Intern. Med. 2018. Vol. 178, N. 2. P. 229-238.
Wang M., Tsai C., Lin C.W., Yeh C. et al. Association between antipsychotic agents and risk of acute
respiratory failure in patients with chronic obstructive pulmonary disease // JAMA Psychiatry. 2017. Vol.
74, N. 3. P. 252-260.
Wang M.T., Lo Y.W., Tsai C.L. et al. Statin use and risk of COPD exacerbation
requiring hospitalization // Am. J. Med. 2013. Vol. 126, N. 7. P. 598-606.
Wang P.S., Avorn J., Brookhart M.A. et al. Effects of noncardiovascular comorbidities on
antihypertensive use in elderly hypertensives // Hypertension. 2005. Vol. 46,
N. 2. P. 273-279.
Источник KingMed.info
390
Wang T., Wang F., Gou Z., Tang H. et al. Using real-world data to evaluate the association of incretin-
based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from
observational studies // Diabetes Obes. Metab. 2015. Vol. 17,
N. 1. P. 32-41.
Wang W., Zhang B. Statins for the prevention of stroke: a meta-analysis of randomized controlled trials
// PLoS One. 2014. Vol. 9, N. 3. Article ID e92388.
Wang Y., Lichtman J.H., Dharmarajan K. et al. National trends in stroke after acute myocardial infarction
among Medicare patients in the United States: 1999 to 2010 // Am. Heart J. 2014. Vol. 169. P. 78-85.e4.
Wang Z., Li Y., Zhou F., Piao Z. et al. Effects of statins on bone mineral density and fracture risk: a
PRISMA-compliant systematic review and meta-analysis // Medicine (Baltimore). 2016. Vol. 95, N. 22.
Article ID e3042.
Wang Z., Zhang Y., Gao M. et al. Statin therapy for the prevention of atrial fibrillation: a meta-analysis
of randomized controlled trials // Pharmacotherapy. 2011. Vol. 31,
N. 11. P. 1051-1062.
Wang J.W., Hsu C.N., Tai W.C. et al. The Association of Helicobacter pylori Eradication with the
Occurrences of Chronic Kidney Diseases in Patients with Peptic
Ulcer Diseases // PLoS One. 2016. Vol. 11, N. 10. e0164824.
Wang Z.J., Harjai K.J., Shenoy C. et al. Drug-eluting stents versus bare-metal stents in patients with
decreased GFR: ameta-analysis // Am. J. Kidney Dis. 2013. Vol. 62, N. 4. P. 711-721.
Washam J.B., Stevens S.R., Lokhnygina Y. et al. Digoxin use in patients with atrial fibrillation and adverse
cardiovascular outcomes // Lancet. 2015. Vol. 385. P. 2363-
2370.
Weber M.A., Mansfield T.A., Cain V.A. et al. Blood pressure and glycaemic effects of dapagliflozin versus
placebo in patients with type 2 diabetes on combination antihypertensive therapy // Lancet Diabetes
Endocrinol. 2016. Vol. 4, N. 3. P. 211-220.
Webster Louise M, Conti-Ramsden Frances, Seed Paul T, et al. Impact of Antihypertensive Treatment on
Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic
Review and Meta-Analysis. Journal of the American Heart Association. 2017;6(5).
Wedemeyer R.S., Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an
update // Drug Saf. 2014. Vol. 37, N. 4. P. 201-211.
Wei A., Gu Z., Zhang C. et al. Increased risk of myocardial infarction with dabi-gatran etexilate: fact or
fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials
and real-world studies // Int. J. Cardiol. 2018.
Vol. 267. P. 1-7.
Wei F., Lin X. Diabetes increases morbidity and mortality rates in peptic ulcer bleeding: an updated
systematic review and meta-analysis // Turk. J. Gastroenterol.
2016. Vol. 27, N. 4. P. 304-311.
Соседние файлы в папке Библиотека им академика М.И. Перельмана